| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |